These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6790215)

  • 21. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
    Nakajima H; Yui Y; Kawashita K; Yoshida A; Kawai C
    Jpn Circ J; 1982 May; 46(5):468-72. PubMed ID: 7077811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 23. Antihypertensive therapy with prazosin in patients with left ventricular dysfunction. Improvement in cardiac performance and exercise tolerance.
    Massie BM; Chan S
    Chest; 1981 Dec; 80(6):692-7. PubMed ID: 7307590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of prazosin on renal function in chronic congestive cardiac failure.
    Myers JB; Morgan TO; Walker JN
    Med J Aust; 1981 Sep; 2(6):290-1. PubMed ID: 7300762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prazosin long-term treatment in severe chronic cardiac failure (author's transl)].
    Kuck KH; Hanrath P; Zehnke A; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1384-8. PubMed ID: 7449634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure.
    Goldman SA; Johnson LL; Escala E; Cannon PJ; Weiss MB
    Am J Med; 1980 Jan; 68(1):36-42. PubMed ID: 7350803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic studies with prazosin in chronic heart failure.
    Silke B; Lakhani ZM; Taylor SH
    J Cardiovasc Pharmacol; 1981; 3(2):329-35. PubMed ID: 6166804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
    Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
    [No Abstract]   [Full Text] [Related]  

  • 29. Prazosin in the treatment of severe chronic congestive cardiac failure.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prazosin in chronic refractory cardiac insufficiency: results of continuous long-term therapy].
    Sánchez Domínguez J; Villa JG; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Apr; 161(2):113-7. PubMed ID: 7280315
    [No Abstract]   [Full Text] [Related]  

  • 31. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prazosin in chronic congestive heart failure due to ischemic heart disease.
    Antani JA; Antani NJ; Nanivadekar AS
    Clin Cardiol; 1991 Jun; 14(6):495-500. PubMed ID: 1810687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
    Tomov I; Kaloianova A; Terzieva L; Nikolov G; Elenkova A
    Vutr Boles; 1982; 21(6):45-50. PubMed ID: 6761964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
    Franchi F; Michelucci A; Morace G; Porciani MC; Fantini F
    Clin Ter; 1980 Apr; 93(1):3-20. PubMed ID: 7449331
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.
    Higginbotham MB; Morris KG; Bramlet DA; Coleman RE; Cobb FR
    Am J Cardiol; 1983 Oct; 52(7):782-8. PubMed ID: 6353898
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prazosin in the treatment of chronic cardiac insufficiency].
    Champoud O; Cribier A; Letac B
    Ann Med Interne (Paris); 1985; 136(3):261-5. PubMed ID: 2862824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
    Tomov I; Kaloianova A; Terzieva L; Elenkova A; Nikolov G
    Vutr Boles; 1981; 20(6):72-8. PubMed ID: 7039130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure.
    Colucci WS; Holman BL; Wynne J; Carabello B; Malacoff R; Grossman W; Braunwald E
    Am J Med; 1981 Jul; 71(1):75-80. PubMed ID: 6113759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L; Foster PR; Friedman AW; Statza J; McHenry PL
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of prazosin in severe cardiac insufficiency].
    Timio M; Gentili S; Schiaroli M; Ronconi M
    G Ital Cardiol; 1979; 9(12):1371-7. PubMed ID: 549785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.